Baculovirus-produced influenza virus-like particles in mammalian cells protect mice from lethal influenza challenge

Viral Immunology

Volumn 24, Issue 4, 2011, Pages 311-319

  Tang, Xian Chun ^a,b   Lu, Hai Rong ^a   Ross, Ted M ^a,b  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACMAM BV; BACULOVIRUS VECTOR; BV TRANSDUCTION PRODUCED VLP; GREEN FLUORESCENT PROTEIN; HEMAGGLUTINATION INHIBITING ANTIBODY; HEMAGGLUTININ; INFLUENZA VACCINE; INFLUENZA VIRUS LIKE PARTICLE; MATRIX PROTEIN; PLASMID TRANSFECTION PRODUCED VLP; SIALIDASE; UNCLASSIFIED DRUG; VIRUS LIKE PARTICLE VACCINE;

293T CELL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACMAM SYSTEM; BACULOVIRUS; CELL LINE; CLINICAL TRIAL; CONTROLLED STUDY; CULTURE OPTIMIZATION; CYTOMEGALOVIRUS; DRUG EFFICACY; DRUG SAFETY; FEMALE; GENE EXPRESSION SYSTEM; GENE REPLICATION; GENE VECTOR; GENETIC TRANSFECTION; HEMAGGLUTINATION INHIBITION TEST; IMMUNOSTIMULATION; INFLUENZA; INFLUENZA VIRUS; LEPIDOPTERA; MAMMAL CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; VACCINE PRODUCTION; VESICULAR STOMATITIS VIRUS GLYCOPROTEIN GENE; VIRAL GENE DELIVERY SYSTEM; VIROGENESIS; VIRUS GENE; VIRUS HEMAGGLUTINATION; VIRUS PURIFICATION; WESTERN BLOTTING;

ANIMALS; ANTIBODIES, VIRAL; BACULOVIRIDAE; CELL LINE; DISEASE MODELS, ANIMAL; FEMALE; GENETIC VECTORS; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; IMMUNIZATION, SECONDARY; INFLUENZA VACCINES; LUNG; MICE; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE; ORTHOMYXOVIRIDAE INFECTIONS; RODENT DISEASES; SURVIVAL ANALYSIS; TRANSDUCTION, GENETIC; VACCINATION; VACCINES, SYNTHETIC; VACCINES, VIROSOME;

HEXAPODA; MAMMALIA; MUS; ORTHOMYXOVIRIDAE;

EID: 80051726245     PISSN: 08828245     EISSN: 15578976     Source Type: Journal    
DOI: 10.1089/vim.2011.0016     Document Type: Article

References (45)

1. Pinto LA, Edwards J, Castle PE, et al.: Cellular immune responses to human papillomavirus (HPV)-16 L1 in healthy volunteers immunized with recombinant HPV-16 L1 viruslike particles. J Infect Dis 2003;188:327-338. (Pubitemid 36898167)
2. Emeny RT, Wheeler CM, Jansen KU, et al.: Priming of human papillomavirus type 11-specific humoral and cellular immune responses in college-aged women with a virus-like particle vaccine. J Virol 2002;76:7832-7842. (Pubitemid 34761005)
3. Ross TM, Mahmood K, Crevar CJ, et al.: A trivalent viruslike particle vaccine elicits protective immune responses against seasonal influenza strains in mice and ferrets. PloS One 2009;4:e6032.
4. Haynes JR: Influenza virus-like particle vaccines. Exp Review Vaccines 2009;8:435-445.
5. Grgacic EV, and Anderson DA: Virus-like particles: passport to immune recognition. Methods 2006;40:60-65. (Pubitemid 44415499)
6. Pushko P, Tumpey TM, Bu F, et al.: Influenza virus-like particles comprised of the HA, NA, and M1 proteins of H9N2 influenza virus induce protective immune responses in BALB/c mice. Vaccine 2005;23:5751-5759. (Pubitemid 41668881)
7. Quan FS, Huang C, Compans RW, and Kang SM: Virus-like particle vaccine induces protective immunity against homologous and heterologous strains of influenza virus. J Virol 2007;81:3514-3524. (Pubitemid 46456660)
8. Bright RA, Carter DM, Daniluk S, et al.: Influenza virus-like particles elicit broader immune responses than whole virion inactivated influenza virus or recombinant hemagglutinin. Vaccine 2007;25:3871-3878. (Pubitemid 46589748)
9. Bright RA, Carter DM, Crevar CJ, et al.: Cross-clade protective immune responses to influenza viruses with H5N1 HA and NA elicited by an influenza virus-like particle. PloS One 2008;3:e1501.
10. Haynes JR, Dokken L, Wiley JA, et al.: Influenza-pseudotyped Gag virus-like particle vaccines provide broad protection against highly pathogenic avian influenza challenge. Vaccine 2009;27:530-541.
11. Volkman LE, and Goldsmith PA: In vitro survey of autographa californica nuclear polyhedrosis virus interactionwith nontarget vertebrate host cells. Appl Environmental Microbiol 1983;45:1085-1093. (Pubitemid 13146670)
12. Carbonell LF, Klowden MJ, and Miller LK: Baculovirusmediated expression of bacterial genes in dipteran and mammalian cells. J Virol 1985;56:153-160. (Pubitemid 16256867)
13. Hofmann C, Sandig V, Jennings G, et al.: Efficient gene transfer into human hepatocytes by baculovirus vectors. Proc Natl Acad Sci USA 1995;92:10099-10103.
14. Boyce FM, and Bucher NL: Baculovirus-mediated gene transfer into mammalian cells. Proc Natl Acad Sci USA 1996;93:2348-2352. (Pubitemid 26104353)
15. Kost TA, and Condreay JP: Recombinant baculoviruses as mammalian cell gene-delivery vectors. Trends Biotechnol 2002;20:173-180. (Pubitemid 34242859)
16. van Loo ND, Fortunati E, Ehlert E, et al.: Baculovirus infection of nondividing mammalian cells: mechanisms of entry and nuclear transport of capsids. J Virol 2001;75:961-970. (Pubitemid 32037298)
17. Sarkis C, Serguera C, Petres S, et al.: Efficient transduction of neural cells in vitro and in vivo by a baculovirus-derived vector. Proc Natl Acad Sci USA 2000;97:14638-14643. (Pubitemid 32016628)
18. Pieroni L, and La Monica N: Towards the use of baculovirus as a gene therapy vector. Curr Opin Molec Therapeutics 2001;3:464-467. (Pubitemid 32998998)
19. Chuang CK, Sung LY, Hwang SM, et al.: Baculovirus as a new gene delivery vector for stem cell engineering and bone tissue engineering. Gene Therapy 2007;14:1417-1424.
20. Boulaire J, Zhao Y, and Wang S: Gene expression profiling to define host response to baculoviral transduction in the brain. J Neurochem 2009;109:1203-1214.
21. Wu Q, Fang L, Wu X, et al.: A pseudotype baculovirus-mediated vaccine confers protective immunity against lethal challenge with H5N1 avian influenza virus in mice and chickens. Molec Immunol 2009;46:2210-2217.
22. Facciabene A, Aurisicchio L, and La Monica N: Baculovirus vectors elicit antigen-specific immune responses in mice. J Virol 2004;78:8663-8672. (Pubitemid 39025132)
23. Strauss R, Huser A, Ni S, et al.: Baculovirus-based vaccination vectors allow for efficient induction of immune responses against Plasmodium falciparum circumsporozoite protein. Mol Ther 2007;15:193-202. (Pubitemid 46043665)
24. Tani H, Abe T, Matsunaga TM, et al.: Baculovirus vector for gene delivery and vaccine development. Future Virol 2008;3:35-43.
25. Tang XC, Lu HR, and Ross TM: Hemagglutinin displayed baculovirus protects against highly pathogenic influenza. Vaccine 2010;28:6821-6831.
26. Hsu CS, Ho YC, Wang KC, and Hu YC: Investigation of optimal transduction conditions for baculovirus-mediated gene delivery into mammalian cells. Biotechnol Bioengineering 2004;88:42-51.
27. Tani H, Limn CK, Yap CC, et al.: In vitro and in vivo gene delivery by recombinant baculoviruses. J Virol 2003;77:9799-9808. (Pubitemid 37122060)
28. Condreay JP, Witherspoon SM, Clay WC, and Kost TA: Transient and stable gene expression in mammalian cells transduced with a recombinant baculovirus vector. Proc Natl Acad Sci USA 1999;96:127-132. (Pubitemid 29036064)
29. Abramoff M, Magelhaes P, and Ram S: Image Processing with ImageJ. Biophotonics International 2004;11:36-42.
30. Barsoum J, Brown R, McKee M, and Boyce FM: Efficient transduction of mammalian cells by a recombinant baculovirus having the vesicular stomatitis virus G glycoprotein. Human Gene Ther 1997;8:2011-2018.
31. Kenoutis C, Efrose RC, Swevers L, et al.: Baculovirus-mediated gene delivery into mammalian cells does not alter their transcriptional and differentiating potential but is accompanied by early viral gene expression. J Virol 2006;80:4135-4146.
32. Killian ML: Hemagglutination assay for the avian influenza virus. Methods Molec Biology 2008;436:47-52.
33. 1997 Committee for Human Medicinal Products: Note for Guidance on Harmonisation of Requirements for Influenza Vaccines (CPMP/BWP/214/96). London: European Agency for the Evaluation of Medicinal Products.
34. Ludwig C, and Wagner R: Virus-like particles-universal molecular toolboxes. Curr Opin Biotechnol 2007;18:537-545.
35. Roy P, and Noad R: Virus-like particles as a vaccine delivery system: myths and facts. Human Vaccines 2008;4:5-12. (Pubitemid 351785255)
36. Shiosaki K, Takata K, Nishimura S, et al.: Production of hepatitis B virion-like particles in yeast. Gene 1991;106:143-149.
37. Robertson JS, Harrap KA, and Longworth JF: Baculovirus morphogenesis: the acquisition of the virus envelope. J Invertebrate Pathol 1974;23:248-251.
38. Vicente T, Peixoto C, Carrondo MJ, and Alves PM: Purification of recombinant baculoviruses for gene therapy using membrane processes. Gene Therapy 2009;16:766-775.
39. Garland SM, Hernandez-Avila M, Wheeler CM, et al.: Quadrivalent vaccine against human papillomavirus to prevent anogenital diseases. N Engl J Med. 2007;356:1928-1943. (Pubitemid 46740303)
40. Rueda P, Fominaya J, Langeveld JP, et al.: Effect of different baculovirus inactivation procedures on the integrity and immunogenicity of porcine parvovirus-like particles. Vaccine 2000;19:726-734.
41. Kosukegawa A, Arisaka F, Takayama M, et al.: Purification and characterization of virus-like particles and pentamers produced by the expression of SV40 capsid proteins in insect cells. Biochimica Biophysica Acta 1996;1290:37-45. (Pubitemid 26173323)
42. Hu YC, Bentley WE, Edwards GH, and Vakharia VN: Chimeric infectious bursal disease virus-like particles expressed in insect cells and purified by immobilized metal affinity chromatography. Biotechnol Bioengineering 1999;63:721-729. (Pubitemid 29200407)
43. Hu YC, Tsai CT, Chang YJ, and Huang JH: Enhancement and prolongation of baculovirus-mediated expression in mammalian cells: focuses on strategic infection and feeding. Biotechnol Progress 2003;19:373-379.
44. Scott MJ, Modha SS, Rhodes AD, et al.: Efficient expression of secreted proteases via recombinant BacMam virus. Protein Expression Purification 2007;52:104-116. (Pubitemid 46043557)
45. Hervas-Stubbs S, Rueda P, Lopez L, and Leclerc C: Insect baculoviruses strongly potentiate adaptive immune responses by inducing type I IFN. J Immunol 2007;178:2361-2369. (Pubitemid 46233435)